北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学第三临床医学院  > 期刊论文
学科主题: 临床医学
题名:
Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1
作者: Liu Ning1; Xu Ning2; Wei Li-hui3; Chai Guo-lin4
关键词: mammalian target of rapamycin ; osteoclast ; neurofibromatosis type 1 ; rapamycin
刊名: CHINESE MEDICAL JOURNAL
发表日期: 2013-01-05
DOI: 10.3760/cma.j.issn.0366-6999.20121227
卷: 126, 期:1, 页:101-107
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, General & Internal
研究领域[WOS]: General & Internal Medicine
关键词[WOS]: BONE-RESORPTION ; SCHWANN-CELLS ; NF1 ; GROWTH ; TUMORS ; MOUSE ; IMMUNOSUPPRESSANT ; HYPERACTIVATION ; CHILDREN ; THERAPY
英文摘要:

Background Neurofibromatosis type 1 (NF1) is the most common genetic syndrome predisposing patients to various tumors due to dysregulation of the Ras signaling pathway. Recent research has shown NF1 patients also suffer a spectrum of bone pathologies. The pathogenesis of NF1 bone diseases is largely unknown. There is no current treatment. By Nf1 heterozygote (Nf1+/-) mice and Nf1 conditional knockout mice, we and other groups demonstrated abnormal osteoblast and osteoclast function due to dysregulation of Ras signaling. However, the specific downstream effector pathways linked to NF1 abnormal osteoblastogenesis and osteoclastogenesis have not been defined. In this study, we investigated the Ras downstream effector related with NF1 bone disease.

Methods We used Nf1+/+ and Nf1+/- mice as normal and NF1 models. Bone stromal cells extracted from Nf1+/+ and Nf1+/- mice were induced osteoclasts. The osteoclast cell was stained by tartrate resistant acid phosphatase staining. The osteoclast cell number was counted and the surface area of osteoclast cells was calculated under the microscope. The mRNA of mammalian target of rapamycin (mTOR) was determined by quantitative reverse-transcription-polymerase chain reaction. The presence of ribosomal protein S6 kinase was determined by Western blotting.

Results Compared with Nf1+/+ mice, Nf1+/- mice had about 20% more of osteoclast cells. These osteoclast cells were larger in size with more nuclei. Hyperactive mTOR was detected in Nf1+/- osteoclast cells. Inhibition of mTOR signaling by rapamycin in Nf1+/- osteoclasts abrogated abnormalities in cellular size and number.

Conclusion mTOR pathway inhibition may represent a viable therapy for NF1 bone diseases.

语种: 英语
所属项目编号: 985-2-015-24
项目资助者: Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China
WOS记录号: WOS:000319793700019
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/66320
Appears in Collections:北京大学第三临床医学院_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Haidian Maternal & Child Hlth Hosp, Beijing 100080, Peoples R China
2.Peking Univ, Hosp 3, Dept Internal Med, Beijing 100191, Peoples R China
3.Peking Univ, Peoples Hosp, Dept Obstet & Gynecol, Beijing 100044, Peoples R China
4.China Japan Friendship Hosp, Dept Hematol, Beijing 100029, Peoples R China

Recommended Citation:
Liu Ning,Xu Ning,Wei Li-hui,et al. Mammalian target of rapamycin inhibitor abrogates abnormal osteoclastogenesis in neurofibromatosis type 1[J]. CHINESE MEDICAL JOURNAL,2013,126(1):101-107.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Liu Ning]'s Articles
[Xu Ning]'s Articles
[Wei Li-hui]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Liu Ning]‘s Articles
[Xu Ning]‘s Articles
[Wei Li-hui]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2018  北京大学医学部 - Feedback
Powered by CSpace